Mutational Analysis of HIV-1 gp160-Mediated Receptor Interference: Intracellular Complex Formation  by MARTIN, ROBERT A. & NAYAK, DEBI P.
VIROLOGY 220, 461–472 (1996)
ARTICLE NO. 0333
Mutational Analysis of HIV-1 gp160-Mediated Receptor
Interference: Intracellular Complex Formation
ROBERT A. MARTIN and DEBI P. NAYAK1
Department of Microbiology and Immunology, Jonsson Comprehensive Cancer Center, UCLA School of Medicine,
University of California at Los Angeles, Los Angeles, California 90024-1747
Received February 8, 1996; accepted April 15, 1996
Formation of CD4– gp160 intracellular complexes represents an important mechanism leading to the induction of receptor
interference. Previous studies have demonstrated that cells coexpressing gp160 and CD4 formed complexes of CD4 and
gp160 which became blocked within the endoplasmic reticulum (ER), preventing CD4 from reaching the cell surface. In this
report we have investigated the domains and residues of CD4 and gp160 involved in intracellular interaction. Accordingly,
we have introduced mutations in both CD4 and gp160 at sites previously shown to disrupt CD4–gp120 interactions at the
cell surface. Using a T7-vaccinia virus transient expression system, we expressed these gp160 and CD4 mutants in HeLa
cells and analyzed their effects on intracellular complex formation and CD4 surface modulation. We observed that a number
of gp160 mutants which failed to interact with CD4 at the cell surface also failed to bind and trap CD4 within the ER as
expected. However, mutations at a critical residue, W427, did not abrogate intracellular CD4 binding. These gp160 mutants
continued to interact with intracellular CD4 and inhibit CD4 transport to the cell surface, although gp120 produced from
these mutants did not bind CD4 at the cell surface as expected. A number CD4 mutants also continued to form intracellular
complexes with gp160, resulting in the loss of CD4 surface expression. Again, these CD4 mutants did not bind to gp120
at the cell surface, consistent with earlier reports. These results demonstrate that intracellular interactions between gp160
and CD4 in the ER may utilize different contact sites compared to those used during CD4 and gp120 binding at the cell
surface. The data provide further evidence that the environment in which CD4 and the HIV-1 envelope glycoprotein interact
can have a significant effect on their interaction. q 1996 Academic Press, Inc.
INTRODUCTION for CD4 down-regulation have not been precisely de-
fined; however, N-terminal myristolation and the first 20
The down-regulation of CD4 cell surface expression amino acids of Nef have been shown to be essential
following HIV infection, known as receptor interference, (Greenway et al., 1994). Conversely, mutational analysis
is required for induction of superinfection immunity, of CD4 has demonstrated that the membrane-proximal
which is associated with the establishment of a persis- 20 amino acids of the CD4 cytoplasmic domain, including
tent, noncytopathic infection and can result in the loss of a dileucine motif at positions 413 and 414, are necessary
functional T cells without cell death. Despite its potential and sufficient for CD4 internalization by Nef (Aiken et al.,
importance, little is known of the molecular events gov- 1994; Bour et al., 1995).
erning this process. This down-regulation of CD4 has In contrast to Nef, posttranslational down-regulation
been shown to occur by several mechanisms acting at of CD4 by gp160 is mediated by blocking the normal
the level of transcription, translation, and posttranslation maturation and transport of CD4 to the cell surface. The
(Hoxie et al., 1986; Stevenson et al., 1988; Yuille et al.,
envelope glycoprotein binds to CD4 within the endoplas-
1988). Mechanisms which act posttranslationally are the
mic reticulum (ER) soon after synthesis, with a t1/2 ofbest characterized to date. Studies have shown that two
approximately 15 min (Earl et al., 1991a). This complex
viral proteins, Nef and gp160, act independently to down-
becomes blocked within the ER, resulting in the depletion
regulate CD4 from the surface of infected cells (Anderson
of CD4 at the cell surface. In HIV-infected cells, CD4
et al., 1993; Kawamura et al., 1989). Nef-mediated CD4
trapped in the ER is further degraded by Vpu, another
down-regulation is independent of effects on transcrip-
HIV accessory protein, thus ensuring that the blocked
tion or translation and does not affect the normal matura-
CD4 does not escape and reach cell surface (Earl et al.,tion or transport of CD4 to the cell surface. Instead, Nef
1991b; Willey et al., 1992a,b). This loss of CD4 surfaceacts on CD4 present at the cell surface to mediate its
expression can be seen following productive infection ofinternalization and lysosomal degradation (Bour et al.,
T cell and monocytic cell lines in vitro and is accompa-1995; Sanfridson et al., 1994). Nef sequences important
nied by the accumulation of intracellular complexes of
viral glycoproteins and newly synthesized CD4 (Geleziu-
nas et al., 1991; Hoxie et al., 1986; Stevenson et al.,1 To whom reprint requests should be addressed.
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1987). The extent of CD4 surface depletion caused by sential Media (MEM, Gibco-BRL) supplemented with 10%
the formation of such complexes directly correlates with fetal bovine serum (FBS), 250 U of penicillin, and 250 mg
levels of viral activation and production of gp160 (Bour of streptomycin per milliliter. HeLa T4 cells were ob-
et al., 1995; Kawamura et al., 1989). The role of gp160 in tained through the AIDS Research and Reference Re-
the down-modulation of CD4 has been confirmed by a agent Program, Division of AIDS, NIAID, NIH, from Dr.
number of laboratories. Lymphocytic and monocytic Richard Axel (Maddon et al., 1986) and maintained in
cells, engineered to express gp160, contain intracellular Dulbecco’s modified Eagle’s medium (DMEM) containing
CD4–gp160 complexes and show reduced levels of CD4 10% FBS. HeLa env c cells were obtained through the
expression at the cell surface (Geleziunas et al., 1994; AIDS Research and Reference Reagent Program, Divi-
Stevenson et al., 1988). Studies by us and others have sion of AIDS, NIAID, NIH, from Dr. Ruth Ruprecht (Gama
shown that HeLa cells transfected with both CD4 and Sosa et al., 1989).
gp160 expressing constructs produce intracellular CD4 – Recombinant vaccinia virus (vTF7.3) encoding the bac-
gp160 complexes in the ER, which are blocked in trans- teriophage T7 RNA polymerase was kindly provided by
port (Crise et al., 1990; Jabbar and Nayak, 1990; Kawa- B. Moss, NIH.
mura et al., 1989). OKT4 ascites fluid was obtained from C57 black mice
Although much information is available about the na- injected with OKT4 hybridoma cells provided by Dr. Wil-
ture of the gp120–CD4 interaction at the cell surface, liam Clark, UCLA. Mouse anti-gp41 monoclonal antibody
little is known about the nature of intracellular interaction. was purchased from NEN research products (Boston,
Based on results from several labs, it is now accepted MA). Sheep anti-gp120 serum was obtained through the
that the majority of residues important for binding CD4
AIDS Research and Reference Reagent Program, Divi-
are located in conserved regions within the C-terminal
sion of AIDS, NIAID, NIH, from Dr. Michael Phelan.
half of gp120, from C2 to C4 domains (Lasky et al., 1987;
Pollard et al., 1992). Mutations of single amino acids in
the C3 and C4 domains profoundly impair CD4 binding Mutagenesis
and viral infectivity. Both conservative and nonconserva-
tive substitutions of a typtophane residue at position 427 Construction of plasmids encoding gp160 (pGENV-7N)
(C4 domain) have been shown to completely abrogate and CD4 (pGCD4) has been described previously (Jabbar
binding (Cordonnier et al., 1989), while substitutions at and Nayak, 1990). In order to introduce mutations,
amino acids 368, 370 (C3 domain), and 457 (C4 domain) pGCD4 and pGENV-7N encoding CD4 and gp160, re-
severely impair CD4 binding without disrupting the con- spectively, were restricted with EcoRI and BamHI and
formation of gp120 (Olshevsky et al., 1990). 1.7- and 2.8-kb fragments were subcloned into M13
Similarly, a great deal of work has been done to eluci- mp18. Mutations were introduced by site-directed muta-
date the gp120 binding site on CD4. It has been shown genesis using the Sulptor in vitro mutagenesis system
that the membrane distal domain of CD4, D1, contains
(Amersham) and the following synthetic oligonucleotides.
all the residues required for binding to gp120. Further
For gp160 mutants, 257T-R: GCCATTTAACAGCAGTTG-
analysis suggests that the majority of important residues
CCTTGACACTATTGGCC; 368D-R: GCATTACAATTTCTG-
are within the CDR2 domain (aa 26–57) of D1 (Richard-
GGCGCCCTCCTGAGG; 370E-R: GCATTACAAATTCTT-son et al., 1988). Epitope mapping of CD4 substitution
GGGTCCCCTCC; 457D-A: CATTTGTACCACCAGCTCmutants with monoclonal antibodies confirms that amino
TTGTTAATAGCAGCCCTGTAATATTTG; 427W-S: CCT-acids 41–52 are involved in gp120 binding (Sattentau et
ACTTCCTGACTATGTTTAT; 427W-V: CCTACTTCC-al., 1989). In addition, substitution of amino acids from
TGAACCATGTTTAT; 427DMWQ: GCTTTTCCTACTTCG-the mouse CD4 (L3T4) D1 domain onto human CD4 dem-
TTTATAATTTGTTTTA.onstrates that residues 38–57 are indispensable for
For CD4 mutants, 43F-V: CCTTTAGTTAAGACGGAG-gp120 binding at the cell surface (Landau et al., 1988).
CCCTGATTT; 52[F]53: GCTTCTTCTTGAGTCAGCGGA-Recently, more precise mutagenesis studies have con-
TCAAAATTCAGCAG; 55A-F: GGCTTCTTCTTGAGTCAA-firmed that substitution and insertions between residues
AGCGATCATTC.41 and 59 result in decreased binding to gp120 without
Following mutagenesis, RF from M13 mp18 clonesdisrupting CD4 conformation (Arthros et al., 1989). In this
were restricted with EcoRI and BamHI and fragmentsreport we have examined if the residues of CD4 and
encoding CD4 and gp160 were subcloned into pGEM-3gp160 involved in their interaction at the cell surface are
(Promega) under the control of the T7 polymerase pro-also involved in their intracellular interaction in the ER.
moter. All DNA constructs were sequenced to confirm
MATERIAL AND METHODS the mutations and two independent clones of each mu-
Cells, viruses, and antibodies tated CD4 and gp160 fragment were used to ensure that
spontaneous mutations distant from the desired muta-HeLa cells were obtained from American Type Culture
Collection (Rockville, MD) and maintained in Minimal Es- tions were not responsible for the observed phenotypes.
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Expression, pulse–chase, immunoprecipitation, and washed twice with PBS/, fixed in 4% formaldehyde solu-
endoglycosidase H (endo H) treatment tion for 10 min, and used for surface staining. For internal
staining, fixed cells were washed with PBS/ and perme-
Approximately, 2 1 106 HeLa cells were layered on to
abilized with 1% NP-40 for 5 min. Slides were incubated
60-mm culture dishes the night before. These dishes
overnight at 47 in PBS/ containing 0.2% gelatin (PBS-G).
were then infected with recombinant vaccinia virus
Cells were incubated with OKT4 or anti-gp41 (1:100) in
vTF7.3 at a multiplicity of infection (m.o.i.) of 1 in 0.5 ml
PBS–G for 1 hr at 377, and washed three times with PBS-
of phosphate-buffered saline (PBS) containing 0.68 mM
G, followed by incubation with fluorescein-conjugated
Ca2/ and 0.50 mM Mg2/ (PBS/) for 1 hr at 377. The
goat anti-mouse antibody (Cappel) diluted 1:100 in PBS-
inoculum was then removed, and the cells washed once
G for 1 hr at 377. The slides were then washed threewith PBS/. The cells were then transfected with 15 mg
times in PBS-G and mounted in Gelvatol (Monsanto)–of each plasmid DNA in 2 ml of MEM supplemented with
glycerol solution containing DABCO (Sigma). Transmis-2.5% FBS using Lipofectin reagent (Gibco-BRL). At 14–
sion fluorescence microscopy was performed using a16 hr posttransfection (hpt), cells were washed twice
Nikon optiphot microscope (Nippon Kogaka K.K.).with MEM lacking cysteine and methionine, incubated
in same medium for 30 min, and labeled for times indi-
cated with 150 mCi/ml Translabel and 100 mCi/ml [35S]- CD4–gp120 binding assays
cysteine (ICN) in 1 ml MEM lacking cysteine and methio-
nine. Cells were then washed twice with MEM, 2.5% For determining the binding of mutant gp120, gp160
FBS containing an excess of unlabeled methionine and mutant constructs were transfected into HeLa cells (4 1
cysteine and incubated in the same medium at 377 for 106) in 60-mm dishes. At 16 hpt cells were labeled with
the times indicated. 150 mCi/ml of Translabel (ICN) and 100 mCi/ml of [35S]-
At times indicated, cells were washed once with ice- methionine for 2 hr at 377. The 2 ml culture media con-
cold PBS/ and lysed in 0.5 ml of lysis buffer [50 mM taining labeled gp120 was collected and concentrated
Tris–HCl (pH 7.6), 150 mM NaCl, 0.5% Triton X-100, 0.5% to approximately 100 ml using a Centricon-30 micro-
sodium deoxycholate] for 5 min on ice and nuclei were concentrator (Amicon) to remove free radioactive amino
removed by centrifugation at 12,000 g for 3 min. Sodium acids. Samples were then diluted to 500 ml with PBS/
dodecyl sulfate (SDS) was added to a concentration of and incubated for 2 hr at 47 on HeLa cells with rocking.
0.1% and the lysate precleared with 50 ml of Pansorbin HeLa cells that were transfected with the wild-type (WT)
(Calbiochem) on ice for 20 min. Antibodies (3 ml) were CD4 encoding plasmid the day before expressed high
added to the clarified cytoplasmic lysates and incubated levels of CD4. The unbound gp120 in the medium was
at 47 with shaking for 1 hr. Protein G–Sepharose (20 ml, removed, the dishes were washed twice with PBS/, and
Pharmacia) was added and the samples were incubated the cell-bound gp120 was immunoprecipitated with
for 1 hr at 47 with shaking. Sepharose beads containing
sheep anti-gp120 and analyzed by SDS–PAGE as de-
immune complexes were precipitated and washed three
scribed above.
times with lysis buffer containing 0.1% SDS and 1 M
For determining the gp120 binding to mutant CD4, theNaCl. After the final wash, 20 ml of 0.1% SDS was added
CD4 mutant constructs were transfected into HeLa cellsto the beads and boiled for 2 min, followed by addition
as described above. At 16 hpt the CD4 expressing cellsof 180 ml water and an additional 2 min of boiling. Sepha-
were washed and incubated with radiolabeled wild-typerose beads were removed by centrifugation, and each
gp120, which had been prepared as described above.sample was split in half. One-half was incubated with 10
Following a 2-hr incubation at 47 with rocking, the cellsmU of endoglycosidase H (endo H, Boehringer-Mann-
were then washed twice with PBS/ and the bound gp120heim) overnight at 377 and the other half was mock-
was immunoprecipitated with sheep anti-gp120 and ana-treated. Immunoprecipitates were concentrated by
lyzed as described.Speed-Vac and analyzed by electrophoresis on SDS
(0.1%) polyacrylamide (8%) electrophoresis gels (SDS –
PAGE) (Laemmli, 1970). Syncytium assays
Indirect immunofluorescence (IF) HeLa T4 or HeLa env c cells (2 1 106/60-mm dish)
were grown overnight. Cells were then infected withHeLa cells (2 1 105) were grown on glass chamber
vTF7-3 at an m.o.i. of 1 as described above. HeLa T4 orslides (Nunc, Inc.) in MEM containing 10% FBS at 377
HeLa env c cells were then transfected with plasmidsovernight. Cells were then washed with PBS/ and incu-
(15 mg) encoding gp160 mutants or CD4 mutants, respec-bated with vTF7.3 (m.o.i. 1) in PBS/ for 1 hr at 377. The
tively, using Lipofectin. Number of syncytia per high-pow-cells were then transfected with 7.5 mg of each plasmid
ered field (HPF) was then measured at selected times.DNA in 2 ml of MEM, 2.5% FBS using Lipofectin Reagent
(Gibco-BRL) and incubated for 12–14 hr. Cells were then An average of five fields was recorded for comparison.
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this and all subsequent immunoprecipitations the
amount of antibody used was determined to be in excess.
Immunoprecipitations were then divided in half. One half
was digested with endo H, the other half mock-treated,
and the samples were analyzed by SDS–PAGE (Fig. 1).
Following 3 hr chase, the majority (80%) of the CD4
expressed alone became endo H resistant as expected,
indicating that CD4 was transported efficiently to the me-
dial Golgi. CD4 has two N-linked glycans, one of which
normally acquires resistance to endo H digestion due to
the addition of complex sugars (Fig. 1, compare lanes 3
and 4). HIV gp160 expressed alone was also precipitated
from lysates (Fig. 1, lanes 5 and 6). As expected, gp160
was sensitive to endo H digestion. The envelope glyco-
protein has many N-linked glycans, and some of them
attain resistance to endo H at the same time gp160 isFIG. 1. Coexpression and coprecipitation of CD4 and gp160. HeLa
cells were infected with recombinant vaccinia virus vTF7-3 (m.o.i. 1) cleaved to form gp120 and gp41.
and transfected with cDNAs encoding CD4 and gp160 or mock When gp160 and CD4 were coexpressed, both pro-
transfected. At 16 hpt cells were pulse-labeled for 30 min and then teins could be coprecipitated as a complex by either
incubated in chase media for 3 hr prior to lysis. Cell lysates were
antibody to CD4 or gp160 (Fig 1, lanes 7–10). In addition,divided in half and immunoprecipitated with OKT4 (lanes 1, 3 and 4, 7
CD4 remained mostly endo H sensitive, indicating thatand 8) or anti-gp41 (lanes 2, 5 and 6, 9 and 10). Immunoprecipitates
were divided in half, and digested with 10 mU of endo H (/) or mock CD4 transport into the Golgi was inhibited (compare
digested (0). Samples were analyzed by SDS–PAGE followed by fluo- lanes 7–10 with lanes 3 and 4). In these and subsequent
rography. *Indicates endo H-sensitive proteins. Arrowheads indicate experiments, unless stated otherwise, 15 mg of each DNA
position of partially endo H-resistant CD4. Molecular weight markers
was used for transfection as this amount of DNA was(in thousands) are shown on the left. The DNAs used to transfect the
found optimum for coexpression and complex formationcells are indicated above the lanes.
using the WT constructs.
RESULTS Mutations in gp160 and CD4 result in loss of gp120–
CD4 binding in soluble assaysCD4 and gp160 form intracellular complexes
Previous studies have shown that intracellular CD4 – Mutations were made in both gp120 and CD4 at
residues which have been shown previously to disruptgp160 complexes become blocked within the ER, pre-
venting the transport of CD4 to the Golgi (Crise et al., the interaction between CD4 and gp120 (Cordonnier
et al., 1989; Olshevsky et al., 1990; Landau et al., 1988;1990; Jabbar and Nayak, 1990). To confirm these results,
we expressed CD4 and gp160 alone or together in HeLa Arthros et al., 1989). Mutations in gp160 included: a
threonine to arginine substitution at amino acid 257,cells using the recombinant vaccinia virus T7 polymerase
expression system (Fuerst et al., 1987). Plasmid DNAs 257T-R (C2 domain); an aspartic acid to arginine sub-
stitution at amino acid 368, 368D-R (C3 domain); a glu-encoding gp160 and CD4 under the control of the bacte-
riophage T7 RNA polymerase promoter were transfected tamic acid to arginine substitution at amino acid 370,
370E-R (C3 domain); a tryptophan to serine and valineinto HeLa cells that had been previously infected with
recombinant vaccinia virus encoding the bacteriophage substitution at amino acid 427, 427W-S, 427W-V, and
a deletion of MWQ, 427DMWQ (C4 domain), and anT7 RNA polymerase (1 m.o.i.). We observed that this sys-
tem yields high levels of protein expression. Transfection aspartic acid to alanine substitution at amino acid 457,
457D-A (C5 domain). For cell surface binding, weefficiency was approximately 75–85%, and when plas-
mids encoding two different proteins are cotransfected transfected plasmids encoding these gp160 mutants
into HeLa cells which were labeled for 2 hr at 16 hpt.using this procedure, there is greater than 95% coexpres-
sion (Crise et al., 1990; Jabbar and Nayak, 1990). The labeled gp120, shed into the medium, was col-
lected and used for binding to cells expressing CD4HeLa cells transfected with plasmids encoding CD4
or gp160 or both gp160 and CD4 were metabolically on the surface as described under Materials and Meth-
ods. The results show that each of the mutant and WTlabeled with [35S]methionine and [35S]cysteine for 30 min
and then incubated in the presence of excess unlabeled gp160 plasmids shed large amounts of labeled gp120
into the medium. However, only the WT gp160 boundcysteine and methionine for 3 hr. The cell lysates were
immunoprecipitated with OKT4 (anti-CD4) or anti-gp41 significantly (30%) to CD4/ HeLa cells. None of the
other gp120 mutants bound to cell surface CD4 (Fig.antibody. OKT4 was used because it recognizes an epi-
tope outside of the site of CD4–gp120 interaction. For 2A) as reported previously (Olshevsky et al., 1990).
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FIG. 2. Cell surface binding and syncytium formation of wild-type and mutant gp120 and CD4. (A) HeLa cells were infected with vTF7-3 (m.o.i. 1)
and transfected with pGCD4. At 16 hpt the cells were washed twice with PBS/ and incubated for 2 hr at 47 with PBS/ solution containing labeled
wild-type gp120 or mutant gp120 molecules prepared as described under Material and Methods. The unbound labeled gp120 was removed, and
the cells washed twice with PBS/, lysed, and immunoprecipitated for bound (B) gp120. Parallel samples were used for determining total (T) gp120.
The position of gp120 is indicated by the arrow. (B) HeLa T4 cells were infected with vTF7-3 and transfected with plasmids encoding wild-type
gp160 or each of the mutated gp160 molecules. At the indicated times, the number of syncytia were counted for 5 high-powered fields (HPF) and
an average was plotted. (C) HeLa cells were infected with vTF7-3 and transfected with constructs expressing the WT or mutated CD4. At 16 hpt
cells were washed twice with PBS/ and incubated for 2 hr at 47 with 0.5 ml of a PBS/ solution containing radiolabeled wild-type gp120 prepared
as described under Material and Methods. The unbound labeled gp120 was removed, and cell lysates containing the bound (B) gp120 were
immunoprecipitated. ‘‘T’’ represents the total gp120 (0.5 ml) used for the binding assay. CD4 molecules expressed in the dishes are indicated above
the lanes. The arrowhead indicates the position of gp120. (D) HeLa env c cells were infected with vTF7-3 and transfected with plasmids encoding
the WT or mutant CD4 molecules. At the indicated times the number of syncytia in 5 HPF were counted and the average was plotted.
Mutations in CD4 included a phenylalanine to valine transfected with plasmids encoding gp160 mutants or
CD4 mutants, respectively. At various times, the numbersubstitution at amino acid 43, (43F-V), a phenylalanine
insertion between amino acids 52 and 53 (52[F]53), of syncytia per HPF was noted for each of the constructs.
The results demonstrated that only the WT gp120 andand an alanine to phenylalanine substitution at amino
acid 55 (55A-F), as these mutations have been shown CD4 combination produced syncytia, while mutants were
unable to induce syncytia, consistent with lack of CD4–to affect gp120 binding (Arthros et al., 1989). To test
the ability of these CD4 mutants to bind WT gp120, gp120 interaction at the cell surface (Figs. 2B and 2D).
plasmids encoding CD4 mutants were transfected into
HeLa cells. At 16 hpt, transfected cells were incubated Mutations of gp160 that disrupt intracellular
with the radiolabeled WT gp120, prepared as de- interaction with CD4
scribed above. The bound gp120 was determined by
immunoprecipitation with anti-gp120 antibody, and To determine if mutations made in gp160 affected the
intracellular binding of CD4, HeLa cells were cotransfectedSDS – PAGE analysis (Fig. 2C). Again, only cells ex-
pressing the WT CD4 at the cell surface were able with the WT CD4 expression plasmid, pGCD4, and with one
of the mutant gp160 expression plasmids, 257T-R, 368D-R,to bind the radiolabeled gp120, and none of the CD4
mutants at the cell surface bound gp120 (Fig. 2C), con- 370E-R, or 457D-A. At 16 hpt the cells were pulse-labeled
with [35S]methionine and [35S]cysteine for 30 min, andsistent with previous reports (Arthros et al., 1989). All
CD4 mutants were shown to express at the surface of chased for 3 hr. Aliquots of cell lysates were immunoprecip-
itated with either anti-CD4 or anti-gp41 antibodies. Precipi-transfected cells (Fig. 6).
Since syncytium formation requires interaction of cell tates were digested with or without endo H and analyzed
by SDS–PAGE. The results demonstrated that these muta-surface CD4 with gp120, we evaluated the ability of these
mutant glycoproteins to mediate syncytium formation tions in gp160 severely interfered with their ability to form
CD4–gp160 complexes in the cytoplasm of cotransfected(Figs. 2B and 2D). HeLa cells which constitutively ex-
press CD4 (HeLa T4/) or gp160 (HeLa env c) were cells. For 257 T-R, 368 D-R, and 370 E-R mutants neither
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and also differing the ratios of plasmid DNA in cotransfec-
tion did not affect the outcome. On the other hand, WT CD4
and gp160 cotransfection always demonstrated complex
formation in these experiments (data not shown).
To determine if this lack of binding also resulted in
the increased expression of CD4 at the cell surface, we
investigated CD4 surface expression by indirect immuno-
fluorescence (IF) (Fig. 4). HeLa cells grown on slides
were transfected with plasmids encoding gp160 mutants
alone or in combination with pGCD4. At 16 hpt, cells
were fixed and then stained with OKT4 and anti-gp41
with and without permeabilization. Each of the mutant
gp160 constructs, transfected alone or cotransfected
with CD4, gave expression patterns and intensity of stain-
ing similar to those of the WT gp160 after permeabiliza-
tion (data not shown), while the surface expression of
CD4 upon cotransfection varied. CD4, expressed alone,
resulted in strong staining at the cell surface (Fig. 4A),
whereas CD4 coexpressed with the WT gp160 exhibited
decreased surface expression as expected (Fig. 4B).
However, the internal expression of CD4 in the cotrans-
fected cells as determined by IF staining of permeabil-
ized cells was not affected (data not shown). Coexpres-
sion of CD4 with each of the above gp160 mutants did
not inhibit the surface expression of CD4 (Figs. 4C–4F).
Taken together, these results suggest that residues 257,
368, 370, and 457 are critical for both cell surface and
intracellular interaction between gp160 and CD4.
Mutations of gp160 at amino acid 427 do not
completely disrupt gp160–CD4 intracellular complex
formation
Tryptophane at position 427 (427W) is considered toFIG. 3. Coexpression if mutant gp160 with wild-type CD4. Hela cells
were infected with vTF7-3 (m.o.i. 1) and then transfected with constructs be a crucial residue for gp120:CD4 interaction, as both
encoding CD4 alone or cotransfected with CD4 and gp160 mutants. At conservative and nonconservative changes of this resi-
16 hpt, cells were pulse-labeled for 30 min and incubated in chase due were shown to abrogate the ability of gp120 to inter-media for 3 hr. Cell lysates were divided and immunoprecipitated using
act with CD4 (Cordonnier et al., 1989; Olshevsky et al.,OKT4 (lanes 1–4, 7 and 8, 11 and 12, 15 and 16, 19 and 20, 23 and
1990). We therefore made two substitutions (427W-S and24, 27 and 28) or anti-gp41 (lanes 5 and 6, 9 and 10, 13 and 14, 17
and 18, 21 and 22, 25 and 26, and 29 and 30) antibodies. Precipitates 427W-V) and one deletion mutant at residue 427
were divided in half and digested with 10 mU endo H for 16 hr at 377 (/) (427DMWQ) and tested for their ability to bind and block
or mock digested (0). *Indicates endo H-sensitive proteins. Positions of CD4 within the ER. When these mutant gp160 constructsmolecular weight markers (in thousands) are shown at the right. The
were coexpressed with the WT CD4 in HeLa cells, weDNAs used to transfect the cells are indicated above the lanes. Arrow-
observed that mutations at position 427 did not com-heads indicate position of partially endo H-resistant CD4.
pletely abrogate intracellular complex formation (Fig. 3).
In each case, treatment with either OKT4 antibody (Fig.
3 lanes 19 and 20, 23 and 24, and 27 and 28) or anti-anti-CD4 nor anti-gp41 antibodies coprecipitated gp160 or
CD4, respectively (Fig. 3). For 457 D-A, anti-CD4 antibodies gp41 antibody (Fig. 3 lanes 21 and 22, 25 and 26, and
29 and 30) resulted in coprecipitation of CD4–gp160coprecipitated a small amount of gp160, but anti-gp41 anti-
bodies did not coprecipitate detectable amounts of CD4 complexes and the CD4 in the complex was predomi-
nantly endo H sensitive, suggesting that the complexed(Fig. 3). In addition, the CD4 precipitated in these cotrans-
fected cells was found to be predominantly endo H resis- CD4 was blocked in transport (Fig. 3 lanes 21 and 22,
25 and 26, and 29 and 30). However, a significant fractiontant, suggesting that CD4 was efficiently transported. This
lack of complex formation was not because the same cells of the CD4 immunoprecipitated by CD4 antibody exhib-
ited endo H resistance after 3 hr chase, indicating thatwere not cotransfected by both CD4 and mutant gp160
plasmids, as greater than 90% of cells were cotransfected some CD4 was able to reach the Golgi (Fig. 3 lanes 19
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FIG. 4. Cell surface staining of CD4 in HeLa cells coexpressing CD4 and gp160 mutants. HeLa cells were grown on chamber slides for at least
12 hr. Cells were then infected with vTF7-3 and cotransfected with cDNAs encoding CD4 and the WT gp160 (A) or mutant gp160 (B–F). At 16 hpt,
cells were fixed and surface stained for CD4 as described under Materials and Methods. (A) pGCD4; (B) pGCD4 / PGENV-7N; (C) pGCD4 / 257T-
R; (D) pGCD4 / 368 D-R; (E) pGCD4 / 370E-R; (F) pGCD4 / 457 D-A; (G) pGCD4 / 427 W-V.
and 20, 23 and 24, and 27 and 28). Indirect immunofluo- interactions at the cell surface. Whereas some resi-
dues are critical for both intracellular and cell surfacerescence staining also confirmed that CD4 surface ex-
pression in these coexpressing cells was considerably binding, others are required predominantly for cell sur-
face binding and not for intracellular interactionsreduced, but still a significant amount of CD4 was ob-
served at the cell surface when compared to cells coex- within the ER.
pressing WT gp160 and CD4 (Fig. 4G, 427 W-V). Similar
results were obtained for 427 W-S and 427DMWQ (data Mutations in CD4 do not disrupt intracellular binding
not shown). The reason for this increased cell surface
expression of CD4 on these coexpressing cells remains Three changes were made in the D1 domain of CD4
at positions which have been shown previously to beunclear. The possibility exists that the intracellular bind-
ing of the mutant gp160 was less efficient or less stable critical for binding to gp120, a phenylalanine to valine
substitution at residue 43 (43 F-V), a phenylalanine inser-(compare Figs. 1 and 3) or that CD4 expression was more
efficient, causing some CD4 to escape gp160 binding in tion between residues 52 and 53 (52[F]53), and an ala-
nine to phenylalanine substitution at position 55 (55A-F)these experiments. However, repeated experiments and
varying the ratios of cotransfected DNAs yielded similar (Arthros et al., 1989; Landau et al., 1988; Richardson et
al., 1988; Sattentau et al., 1989). We also confirmed thatresults.
Despite this increased cell surface CD4, it is clear these CD4 mutants were unable to bind the WT gp120
at the cell surface or cause syncytium formation (Figs.that unlike lack of any interaction of these gp120 mu-
tants with CD4 at the cell surface (Figs. 2A and 2B), a 2C and 2D). For determining their role in intracellular
complex formation, these mutants were coexpressedsignificant amount of intracellular complex formation
was occurring between these gp160 gp427W mutants with the WT gp160 constructs in HeLa cells, and at 16
hpt these cells were pulse-labeled for 30 min and chasedand WT CD4. These results demonstrate that variation
exists between the intracellular complex formation and 3 hr. Lysates were immunoprecipitated with either OKT4
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light of the results obtained by others (Olshevsky et al.,
1990) and by us (Fig. 2). The possibility existed that the
difference was due to the fact that previous studies were
based on assays involving the interaction of membrane-
bound CD4 with soluble gp120, and not between two
membrane bound proteins as was the case within the
ER. In an attempt to address this question, we introduced
stop codons into each of the gp160 constructs at the
junction between the ectodomain and the transmem-
FIG. 5. Coexpression of mutated CD4 and wild-type gp160. HeLa
cells were infected with recombinant vaccinia virus vTF7-3 (m.o.i. 1)
and cotransfected with cDNAs encoding wild-type gp160 and mutated
CD4. At 16 hpt, cells were pulse-labeled for 30 min chased for 3 hr
prior to lysis. Cell lysates were divided in half and immunoprecipitated
with OKT4 (lanes 1 and 2, 5 and 6, and 9 and 10) or anti-gp41 (lanes
3 and 4, 7 and 8, and 11 and 12). Immunoprecipitates were divided in
half, and digested with 10 mU of endo H (/) or mock digested (0).
Samples were analyzed by SDS –PAGE followed by fluorography. *Indi-
cates endo H-sensitive proteins. Molecular weight markers (in thou-
sands) are shown on the left. The DNAs used to transfect the cells are
indicated above the lanes. Arrowheads indicate positions of partially
endo H-resistant CD4. *Indicate gp41 molecules.
or anti-gp41 antibodies, treated with endo H, and ana-
lyzed by SDS–PAGE. The results demonstrated that un-
like the complete lack of interaction at the cell surface,
these CD4 mutants were unable to disrupt the ability of
CD4 to interact with WT gp160 intracellularly (Fig. 5). In
each case, CD4 and gp160 complexes could be precipi-
tated with OKT4 or anti-gp41. Endo H treatment revealed
that CD4 in the complex remained primarily endo H sen-
sitive throughout the chase period, suggesting that CD4
mutants were blocked in the ER.
These results were confirmed by indirect IF. The CD4
mutants were expressed alone or coexpressed with WT
gp160 in HeLa cells grown on glass slides. At 16 hpt
the slides were fixed and stained with OKT4 antibody
followed by fluorescein-conjugated goat anti-mouse anti-
body. The WT and mutant CD4 expressed alone reached
the cell surface (Figs. 6A, 6C, 6E, and 6G). However,
when coexpressed with the WT gp160, surface expres-
sion of the WT and mutant CD4 was markedly reduced
(Figs. 6B, 6D, 6F, and 6H) although the intracellular stain-
ing of CD4 in these coexpressing cells was essentially
similar (data not shown). These results were consistent
with the formation of intracellular gp160–CD4 complexes
leading to the modulation of CD4 surface expression.
Taken together, these experiments indicate that muta-
FIG. 6. Surface expression of CD4 mutants. HeLa cells were growntions in CD4 that are critical for cell surface binding of
on chamber slides, infected with vTF7-3, and transfected with plasmidsgp120 do not disrupt intracellular binding with gp160.
encoding WT and CD4 mutants alone (A, C, E, G) or cotransfected
with WT gp160 plasmids (B, D, F, H). The cells were fixed with 4%Truncation of constructs containing mutations at
formaldehyde and stained using OKT4 antibody, followed by FITC goatamino acid 427 results in loss of intracellular binding
anti-mouse. (A) pGCD4, (B) pGCD4 / pGENV-7N, (C) 52[F]53, (D)
The result that mutations at position 427 of gp160 did 52[F]53 / pGENV-7N, (E) 55A-F, (F) 55A-F / pGENV-7N, (G) 43F-V, (H)
43F-V / pGENV-7N.not disrupt intracellular binding (Fig. 3) was surprising in
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brane domain or at the junction between gp120 and
gp41. These constructs are designated DTM and D41,
respectively. DTM constructs encode gp120 plus the ec-
todomain of gp41; D41 constructs lack all gp41 se-
quences and therefore express only gp120.
Wild-type gp160D41 or gp160DTM constructs were
cotransfected with pGCD4 encoding WT CD4 into HeLa
cells for 16 hr. The cells were then pulse-labeled for 30
min and chased for 3 hr. Cell lysates were immunoprecip-
itated with OKT4 and anti-gp120 followed by endo H
treatment. The results demonstrated that the WT CD4
and the truncated gp160 proteins formed complexes, al-
beit reduced, that can be coprecipitated by either anti-
body (Fig. 7A). gp160 constructs containing mutations at
amino acid 427 were also truncated similarly and ex-
pressed with the WT CD4. Truncation of these mutants at
the transmembrane domain (427W-SDTM, 427W-VDTM,
and 427DMWQDTM) did result in reduction of intracellu-
lar binding to CD4 (Fig. 7B), although in most cases some
CD4–gp160 complexes could be precipitated from cell
lysates. Therefore lack of membrane anchoring of gp160
mutants could be a factor in reduced interaction with,
and transport block of, CD4 in the ER.
A more dramatic effect was seen when these gp160
mutants were truncated at gp41. 427W-SD41, 427W-
VD41, and 427DMWQD41 express gp120 mutated at
residue 427 as described earlier. When these constructs
were coexpressed with CD4, gp120–CD4 complexes
could not be precipitated by either OKT4 or anti-gp120
(Fig. 7C). These results suggest that one reason for the
discrepancies observed in binding of gp160 and CD4
intracellularly versus extracellularly was due to the possi-
ble influence of gp41 sequences and/or membrane an-
choring on gp120 conformation within the ER.
Truncation of CD4 mutants does not abrogate
intracellular interactions
FIG. 7. (A) Coprecipitation of CD4 and soluble gp160 molecules.
HeLa cells were infected with recombinant vaccinia virus vTF7-3
To determine if the influence of transmembrane or cy- (m.o.i. 1) and transfected with cDNAs encoding CD4 and gp160D41
toplasmic domains was responsible for the results ob- or gp160DTM. At 16 hpt, cells were pulse-labeled for 30 min and
then incubated in chase media for 3 hr prior to lysis. Cell lysatestained with the CD4 mutants, we truncated the WT and
were divided in half and immunoprecipitated with OKT4 (lanes 1mutant CD4 constructs. Stop codons were introduced
and 2, 5 and 6) or anti-gp120 (lanes 3 and 4, 7 and 8). (B) Coexpres-into CD4 constructs at the junction between the D4 do-
sion and coprecipitation of the wild-type CD4 and soluble gp160
main and the transmembrane region. These soluble CD4 mutants with changes at amino acid 427. HeLa cells were infected
constructs were cotransfected with WT gp160 constructs, with vTF7-3 and cotransfected with cDNAs encoding CD4 and solu-
ble gp160 mutants (427W-SDTM, 427W-VDTM, 427DMWQDTM).and complexes precipitated as described (Fig. 8A). Trun-
(C) Coexpression and coprecipitation of wild-type CD4 and solublecation of the mutant CD4 molecules did not inhibit intra-
gp120 mutants (427W-SD41, 427W-VD41, 427DMWQD41). For pan-
cellular complex formation between CD4 and gp160. els B and C, cells were pulse-labeled for 30 min at 16 hpt, cell
Complexes of soluble CD4 mutant proteins and WT lysates were prepared, divided in half, and immunoprecipitated with
gp160 were precipitated from cell lysates, and CD4 re- OKT4 (lanes 1 and 2, 5 and 6, 9 and 10) or anti-gp120 (lanes 3 and
4, 7 and 8, and 11 and 12). Immunoprecipitates were divided in halfmained essentially endo H sensitive throughout the
and digested with 10 mU endo H (/) or mock digested (0). Allchase period. Thus, the presence or absence of trans-
samples were analyzed by SDS – PAGE followed by fluorography.
membrane and cytoplasmic sequences of CD4 does not *Indicates endo H-sensitive proteins. Molecular weight markers (in
appear to explain the differences in results between ex- thousands) are shown on the left. The DNAs used to transfect the
cells are indicated above the lanes.tracellular and intracellular binding of these mutants.
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FIG. 8. (A) Coprecipitation of soluble CD4 mutants and wild-type gp160. HeLa cells were infected with recombinant vaccinia virus vTF7-3 (m.o.i.
1) and cotransfected with cDNAs encoding wild-type gp160 and soluble CD4 mutants. At 16 hpt, the cells were pulse-labeled for 30 min and then
incubated in chase media for 3 hr prior to lysis. Cell lysates were divided in half and immunoprecipitated with OKT4 (lanes 1 and 2, 5 and 6, 9 and
10, and 13 and 14) or anti-gp41 (lanes 3 and 4, 7 and 8, 11 and 12, and 15 and 16). (B) Coprecipitation of CD4 mutants and wild-type gp120. HeLa
cells were infected with recombinant vaccinia virus vTF7-3 (m.o.i. 1) and cotransfected with cDNAs encoding WT gp120 and CD4 mutants. At 16
hr posttransfection, the cells were pulse-labeled for 30 min. Cell lysates were divided in half and immunoprecipitated with OKT4 (lanes 1 and 2, 5
and 6, 9 and 10) or anti-gp120 (lanes 3 and 4, 7 and 8, and 11 and 12). Immunoprecipitates were divided in half and digested with 10 mU of endo
H (/) or mock digested (0). Samples were analyzed by SDS–PAGE followed by fluorography. *Indicates endo H-sensitive proteins. The DNAs used
to transfect the cells are indicated above the lanes. Molecular weight markers (in thousands) are shown on the left.
GP120 forms intracellular complexes with CD4 gp120–CD4 binding and tested the ability of these mu-
tants to bind in an intracellular assay. The results pre-mutants
sented in this report suggest that there are differences
Last, we examined the ability of soluble gp120 to form
in the way CD4 and gp160 interact within the ER when
intracellular complexes with each of the full-length CD4
compared to CD4–gp120 binding at the cell surface.
mutants. We found that coexpression of the CD4 mutants
We observed that mutations at residues 257, 368, 370,
with soluble gp120 resulted in the formation of intracellu-
and 457 of gp160 disrupted both extracellular and intra-
lar complexes which can be precipitated by OKT4 or anti-
cellular interactions between gp160 and WT CD4. How-
gp120 (Fig. 8B). Thus, the ability of the CD4 mutants to
ever, previous results by others have shown that both
form intracellular complexes with gp160 does not appear
conservative and nonconservative mutations in the HIV
to be due to the differences between gp160 and gp120.
envelope glycoprotein at position 427 result in the loss
of CD4 binding in soluble assays (Cordonnier et al., 1989;
DISCUSSION
Olshevsky et al., 1990). We confirmed these results, but
we also found that mutation of this highly conservedIn this report we have examined whether mutations
known to disrupt gp120–CD4 extracellular interactions tryptophan residue did not result in the abrogation of
intracellular CD4–gp160 complex formation. Althoughcan also disrupt gp160–CD4 intracellular interactions.
We introduced mutations at selected sites in both CD4 we found some loss of intracellular CD4 binding with
these mutants, CD4–gp160 complexes could be clearlyand gp160 which were shown previously to abrogate
AID VY 7969 / 6a18$$$501 05-16-96 23:05:50 vira AP: Virology
471ANALYSIS OF HIV-1 gp160-MEDIATED RECEPTOR INTERFERENCE
and specifically coprecipitated from the lysates of HeLa site. Support for the influence of gp160 oligomerization
on CD4 binding comes from a report by Mulligan et al.cells expressing both molecules (Fig. 3).
Similarly, when CD4 mutations known to disrupt CD4 – (1992), who demonstrated that the high affinity of an HIV-
2 envelope glycoprotein for sCD4 was dependent on thegp120 interactions were tested, we found that these mu-
tations did not result in the loss of gp160 binding within multimeric presentation of the gp120 glycoprotein on the
surface of the virus or virus-infected cell. Taken together,the cell. Taken together, these results suggest that the
residues required for binding of gp120 to CD4 at the cell these results support the hypothesis that gp41 se-
quences present in gp160 may influence the binding sitesurface may not be as critical for CD4–gp160 interac-
tions within the ER. for CD4 within the ER.
The lack of significant effect of CD4 mutations on intra-The reason for these differences is unclear at this time.
In the case of gp160, it appears that gp41 sequences cellular complex formation, however, cannot be ex-
plained on the basis of soluble vs membrane-bound mol-may influence the way in which gp120 binds to CD4.
Many of the previous studies used soluble gp120 to eval- ecules. Soluble CD4 mutants continued to bind gp160
within the ER, blocking their transport (Fig. 8A). Thus, theuate the ability of mutants to bind CD4, an approach
now considered to have significant limitations (Eiden and continued binding of these mutants appears to suggest
that alternative sites are available for binding within theLifson, 1992). When we expressed HIV envelope glyco-
protein with mutations at amino acid 427 as soluble ER. This more promiscuous binding may be due to the
fact that proteins within the ER are immature. As such,gp120 molecules, the ability of mutant gp120 to bind
CD4 intracellularly was inhibited, consistent with earlier more sites could be available to bind gp120, making the
known sites of mature CD4 molecules less critical forstudies (Fig. 7C). Thus, we speculate that one explana-
tion for the finding that changes at residue 427 do not intracellular binding. Binding of CD4 to gp160 could also
be influenced by the unique environment of the ER. Thehave as great an effect on intracellular binding is due to
the presence of gp41 sequences which can influence lumen of the ER provides environmental conditions opti-
mized for the folding and oxidation of nascent proteins,the conformation of gp120. Support for this hypothesis
comes from the recent report that a single amino acid including high calcium concentration, oxidizing redox po-
tential, and high concentration of molecular chaperoneschange in gp41 results in subtle conformational changes
in epitopes present on gp120 (Thali et al., 1994). This and folding enzymes. All of these factors could influence
the binding sites available for binding to gp120 (Domschange resulted in the emergence of viral variants which
were resistant to neutralization by sera that neutralized et al., 1993).
The ability of the HIV envelope glycoprotein to modu-the parental virus. Additional support comes from reports
which demonstrate that membrane binding via gp41 can late the expression and transport of CD4 has been the
focus of much research in recent years. However, theimpose conformational constraints on gp120, influencing
its ability to bind CD4 (Moore et al., 1992). Primary iso- molecular mechanisms and in vivo implications of this
phenomenon are unclear at this time. This report sug-lates, in contrast to culture-adapted strains, are resistant
to neutralization by soluble CD4 (sCD4). This difference gests that requirements for intracellular CD4–gp160 in-
teractions may be different than those described foris due, in part, to decreased affinity of gp120 on primary
isolates for sCD4. However, soluble gp120 (sgp120) from CD4–gp120. Further studies in defining the mechanism
by which gp160 down-regulates its cellular receptor andboth types of isolates bind sCD4 with similar affinities.
Thus, this difference in sCD4 binding between sgp120 its role in viral biology may provide important information
for understanding viral pathogenesis, CD4 surface modu-and intact virions indicates that most of the variation in
sCD4 binding was related to differences in the structure lation, and viral persistence.
of 120 bound to intact virions via gp41 (Moore et al.,
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